Open access
Sep 2026
Rational discovery of peptide inhibitors targeting Keap1: a focus on neurodegenerative diseases
Findings suggest that LMEETYEFL and LDYETYEFL are promising candidates for disrupting the Keap1/Nrf2 interaction and experimental validation is necessary to confirm their therapeutic potential and facilitate further biological evaluation.
Nandhini Senthilkumar, Shanthi Veerappapillai
· Frontiers in Bioinformatics · 0 citations